You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 241 No. 2, January 12, 1979 TABLE OF CONTENTS
  JAMA
  •  Online Features
  SPECIAL COMMUNICATION
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (87)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Renin Profiling for Diagnosis and Treatment of Hypertension

John H. Laragh, MD; Robert L. Letcher, MD; Thomas G. Pickering, MD

JAMA. 1979;241(2):151-156.


Abstract

Recent research shows that the renin-angiotensin-aldosterone axis either maintains or causes some or all of the high blood pressure of most patients and demonstrates anew that renin-sodium profiling defines this involvement. Performed with a serum potassium measurement, this now reliable test is useful for primary screening and then, in conjunction with renal vein renin studies or an aldosterone profile, for diagnosis or exclusion of surgically curable renovascular or adrenocortical hypertensions. For the remaining majority with essential hypertension, renin profiling exposes the relative participation of either vasoconstriction or volume factors, thereby guiding simpler, more specific, and predictably effective antirenin or antivolume treatments. Renin profiling identifies those in whom treatment should begin with a β-blocker as opposed to a diuretic while not infrequently also providing baseline information about severity and prognosis in individual patients.

(JAMA 241:151-156, 1979)



Author Affiliations

From the Cardiovascular Center and the Cardiology Division, Department of Medicine, The New York Hospital-Cornell Medical Center, New York.


Footnotes

Reprint requests to Cardiovascular Center, The New York Hospital-Cornell Medical Center, 525 E 68th St, New York, NY 10021 (Dr Laragh).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Renin: friend or foe?
Brown
Heart 2007;93:1026-1033.
ABSTRACT | FULL TEXT  

Hypertension and ethnic group.
Brown
BMJ 2006;332:833-836.
FULL TEXT  

HYPERTENSION: Matching the right drug to the right patient in essential hypertension
Brown
Heart 2001;86:113-120.
FULL TEXT  

Increased Density of Renal Amylin Binding Sites in Experimental Hypertension
Wookey et al.
Hypertension 1997;30:455-460.
ABSTRACT | FULL TEXT  

The Antihypertensive Effect of Verapamil at Extremes of Dietary Sodium Intake
NICHOLSON et al.
ANN INTERN MED 1987;107:329-334.
ABSTRACT  

Dietary Sodium and Essential Hypertension: Some Myths, Hopes, and Truths
LARAGH and PECKER
ANN INTERN MED 1983;98:735-743.
ABSTRACT  

Volume Hormones and Blood Pressure
GENEST
ANN INTERN MED 1983;98:744-749.
ABSTRACT  

Sodium Sensitivity in Normotensive Human Subjects
LUFT et al.
ANN INTERN MED 1983;98:758-762.
ABSTRACT  

Is the Renin-Sodium Profile Helpful in Evaluating Hypertension?
Gifford
JAMA 1980;244:35-37.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1979 American Medical Association. All Rights Reserved.